| Themes | National Drug Policy | Rational Drug Use | Essential Drugs | Access to Drugs | Procurement | Pricing | Supply Systems | Regulation | Monitoring and Quality Assurance | Counterfeiting, Diversion, Corruption | Role of the Private Sector | Pharmaceutical Research and Development | Pharmaceutical Manufacturing Access to medicines is a major determining factor for the achievement of health outcome goals. It depends on several parameters that need to be evaluated and addressed in an integrated management approach to achieve the desired results, such as: - Drug registration and approval
- Financing
- Procurement
- Distribution logistics
- Pricing and reimbursement
- Quality and counterfeiting
- Corruption, diversion
- Rational Drug Use
- Compliance
For further study Information for policy makers on access related issues:
http://www.who.int/medicines/strategy/access/stacmain.shtml
http://www.eldis.org/healthsystems/access/ Information on the TRIPS agreement:
http://www.wto.org/english/tratop_e/trips_e/counciljun01_e.htm MSF access campaign
http://www.accessmed-msf.org/index.asp Pharmaceutical industry access programs: Overview
http://www.ifpma.org/Health/health_intro.aspx HIV/AIDS
http://www.accesstohivcare.org/en/welcome/
http://www.pmtctdonations.org/en/welcome/
http://www.achap.org/
http://www.diflucanpartnership.org/en/welcome/ Trachoma
http://www.trachoma.org/home.asp
Malaria (Coartem)
http://rbm.who.int/cmc_upload/0/000/015/789/CoA_website5.pdf Lymphatic Filariasis
http://www.filariasis.org/index.pl Sleeping Sickness
http://www.who.int/emc/diseases/tryp/ TB Global Drug Facility
http://www.stoptb.org/gdf/ Guinea Worm Eradication
http://www.childinfo.org/eddb/gw/index.htm River blindness
http://www.who.int/ocp/ Polio (vaccination)
http://www.polioeradication.org/ |
RSS